Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Harrow, Inc.(HROW) | 3,990,000 | 3,990,000 | 0 | $179.39M | $133.86M | 23.43% | -$45.53M |
| TG Therapeutics, Inc.(TGTX) | 2,280,000 | 2,260,000 | -20,000 | $53.33M | $68.03M | 11.90% | +$14.70M |
| Codexis, Inc.(CDXS) | 8,770,000 | 8,840,000 | +70,000 | $27.01M | $42.17M | 7.38% | +$15.16M |
| Eton Pharmaceuticals, Inc.(ETON) | 2,780,000 | 2,852,070 | +72,070 | $16.68M | $37.99M | 6.65% | +$21.31M |
| Ocular Therapeutix, Inc.(OCUL) | 5,025,000 | 4,342,500 | -682,500 | $43.72M | $37.08M | 6.49% | -$6.63M |
| Arvinas, Inc.(ARVN) | 1,255,000 | 1,625,000 | +370,000 | $30.91M | $33.64M | 5.89% | +$2.73M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 500,000 | 500,000 | 0 | $26.20M | $27.99M | 4.90% | +$1.79M |
| Immunome, Inc.(IMNM) | 1,237,500 | 2,040,000 | +802,500 | $18.09M | $21.66M | 3.79% | +$3.57M |
| Liquidia Corporation(LQDA) | 1,698,142 | 1,698,142 | 0 | $16.98M | $19.97M | 3.49% | +$2.99M |
| Edgewise Therapeutics, Inc.(EWTX) | 522,500 | 480,000 | -42,500 | $13.95M | $12.82M | 2.24% | -$1.13M |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 820,202 | 1,200,000 | +379,798 | $6.68M | $11.78M | 2.06% | +$5.10M |
| Cargo Therapeutics Inc | 541,437 | 750,000 | +208,563 | $11.83M | $10.81M | 1.89% | -$1.02M |
| Protara Therapeutics, Inc.(TARA) | 1,681,154 | 1,825,000 | +143,846 | $3.08M | $9.64M | 1.69% | +$6.56M |
| Trevi Therapeutics, Inc.(TRVI) | 2,567,990 | 2,317,500 | -250,490 | $8.58M | $9.55M | 1.67% | +$971.0K |
| Jasper Therapeutics, Inc.(JSPR) | 353,500 | 400,000 | +46,500 | $6.65M | $8.55M | 1.50% | +$1.90M |
| Newamsterdam Pharma Company ORDINARY SHARES | 335,000 | 325,000 | -10,000 | $5.56M | $8.35M | 1.46% | +$2.79M |
| Acelyrin Inc | 1,893,660 | 2,235,000 | +341,340 | $9.34M | $7.17M | 1.26% | -$2.16M |
| Nurix Therapeutics, Inc.(NRIX) | 420,000 | 378,500 | -41,500 | $9.44M | $7.13M | 1.25% | -$2.31M |
| Xoma Corp Del | 250,000 | 250,000 | 0 | $6.62M | $6.57M | 1.15% | -$50.0K |
| Vaxcyte, Inc.(PCVX) | 85,000 | 75,000 | -10,000 | $9.71M | $6.14M | 1.07% | -$3.57M |
| Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS) | 0 | 0 | 0 | $4.19M | $6.09M | 1.07% | +$1.90M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 967,000 | 1,767,500 | +800,500 | $3.56M | $5.36M | 0.94% | +$1.80M |
| Biodesix, Inc.(BDSX) | 3,815,000 | 3,465,000 | -350,000 | $6.97M | $5.30M | 0.93% | -$1.67M |
| Karyopharm Therapeutics IncNOTE 3 000 10 1 | 0 | 0 | 0 | $3.96M | $4.67M | 0.82% | +$708.9K |
| Nuvalent Inc | 64,000 | 58,500 | -5,500 | $6.55M | $4.58M | 0.80% | -$1.97M |
| Gossamer Bio, Inc.(GOSS) | 3,665,010 | 4,490,000 | +824,990 | $3.71M | $4.06M | 0.71% | +$356.0K |
| Protagonist Therapeutics Inc | 105,000 | 105,000 | 0 | $4.72M | $4.05M | 0.71% | -$672.0K |
| Essa Pharma Inc | 0 | 2,209,998 | +2,209,998 | $0 | $3.96M | 0.69% | +$3.96M |
| AbCellera Biologics Inc.(ABCL) | 800,000 | 965,000 | +165,000 | $2.08M | $2.83M | 0.49% | +$747.5K |
| UroGen Pharma Ltd.(URGN) | 404,100 | 220,000 | -184,100 | $5.13M | $2.34M | 0.41% | -$2.79M |
| Rezolute, Inc.(RZLT) | 466,563 | 465,000 | -1,563 | $2.26M | $2.28M | 0.40% | +$15.7K |
| Immatics N.V.(IMTX) | 0 | 165,000 | +165,000 | $0 | $1.17M | 0.21% | +$1.17M |
| iBio, Inc.(IBIO) | 375,000 | 375,000 | 0 | $832.5K | $918.8K | 0.16% | +$86.3K |
| Lexeo Therapeutics, Inc.(LXEO) | 0 | 130,000 | +130,000 | $0 | $855.4K | 0.15% | +$855.4K |
| REGENXBIO Inc.(RGNX) | 0 | 80,000 | +80,000 | $0 | $618.4K | 0.11% | +$618.4K |
| Ventyx Biosciences | 0 | 280,000 | +280,000 | $0 | $613.2K | 0.11% | +$613.2K |
| PepGen Inc.(PEPG) | 179,200 | 110,000 | -69,200 | $1.53M | $416.9K | 0.07% | -$1.12M |
| Stoke Therapeutics, Inc.(STOK) | 0 | 25,000 | +25,000 | $0 | $275.8K | 0.05% | +$275.8K |
| Adagio Medical Holdings, Inc.(ADGM) | 110,571 | 110,571 | 0 | $285.3K | $116.1K | 0.02% | -$169.2K |
| Aerovate Therapeutics Inc | 440,000 | 0 | -440,000 | $919.6K | $0 | — | -$919.6K |
| Allakos Inc | 2,407,600 | 0 | -2,407,600 | $1.57M | $0 | — | -$1.57M |
| Applied Therapeutics Inc' | 1,320,000 | 0 | -1,320,000 | $11.22M | $0 | — | -$11.22M |
| Catalyst Pharmaceuticals Inc | 112,500 | 0 | -112,500 | $2.24M | $0 | — | -$2.24M |
| Cytokinetics, Incorporated(CYTK) | 75,300 | 0 | -75,300 | $3.98M | $0 | — | -$3.98M |
| Keros Therapeutics, Inc.(KROS) | 395,276 | 0 | -395,276 | $22.95M | $0 | — | -$22.95M |
| Lyell Immunopharma, Inc.(LYEL) | 1,395,000 | 0 | -1,395,000 | $1.93M | $0 | — | -$1.93M |
| Regulus Therapeutics Inc | 535,000 | 0 | -535,000 | $840.0K | $0 | — | -$840.0K |
| Relmada Therapeutics, Inc.(RLMD) | 480,000 | 0 | -480,000 | $1.56M | $0 | — | -$1.56M |
| Revance Therapeutics Inc | 275,000 | 0 | -275,000 | $1.43M | $0 | — | -$1.43M |
| Syros Pharmaceuticals Inc | 654,943 | 0 | -654,943 | $1.41M | $0 | — | -$1.41M |